Are the World Medical Association’s Ethical Standards for Placebos Ethical?

  Guest post by Jeremy Howick  Trials show that drugs called ‘interferon alpha’ can extend life in people with advanced skin cancer by a bit. If we invented a new drug to treat advanced skin cancer, most patients would want to know whether the new drug was better than interferon alpha. It wouldn’t matter much […]

Read More…

Surrogacy, Obstetric Risk and the Kardashian Wests

  Guest post by Nathan Hodson Kim Kardashian West and her husband Kanye West announced the birth of their third child, named Chicago, last month. Chicago West was born via surrogate. All the significant events of Kardashian West’s life have been documented season by season on Keeping Up With The Kardashians and naturally her surrogacy […]

Read More…

Organ Donation in Wales: An Early Assessment of Deemed Consent

Andreas Albertsen Department of Political Science, Aarhus University Paper: Deemed Consent: assessing the new opt-out approach to organ procurement in Wales The shortage of organs for transplant continuous to be a sad fact across the globe. People die and suffer, while waiting for organs to become available. This sad state of affairs have sparked a number […]

Read More…

The Real Problem With Human Head Transplantation

Guest Post: Michael S. Dauber, MA * Note: this article is being cross-posted at the Practical Ethics blog.  In 2015, Sergio Canavero announced that he would perform a therapeutic head transplant procedure on a human subject by December 2017. Since then, he has recruited the assistance of surgeon Xiaoping Ren and switched from Valery Spiridonov to an […]

Read More…

Pedophilia and Child Sexual Abuse Are Two Different Things — Confusing Them is Harmful to Children

By Brian D. Earp (@briandavidearp) Note: this post appeared first at the Practical Ethics blog and is being re-posted. Pedophilia and Child Sexual Abuse Are Two Different Things — Confusing Them is Harmful to Children Republican politician Roy Moore has been accused of initiating sexual contact with a 14-year-old girl when he was in his early […]

Read More…

Does Female Genital Mutilation Have Health Benefits? The Problem with Medicalizing Morality

By Brian D. Earp (@briandavidearp) * Please note: this piece was originally published in Quillette Magazine.     Four members of the Dawoodi Bohra sect of Islam living in Detroit, Michigan have recently been indicted on charges of female genital mutilation (FGM). This is the first time the US government has prosecuted an “FGM” case since a federal law was passed in […]

Read More…

Can We Trust Research in Science and Medicine?

By Brian D. Earp  (@briandavidearp) Readers of the JME Blog might be interested in this series of short videos in which I discuss some of the major ongoing problems with research ethics and publication integrity in science and medicine. How much of the published literature is trustworthy? Why is peer review such a poor quality control mechanism? How can we judge […]

Read More…

Re: Nudges in a Post-truth World 

Guest Post: Nathan Hodson  In a recent article in the Journal of Medical Ethics, Neil Levy has developed a concept of “nudges to reason,” offering a new tool for those trying to reconcile medical ethics with the application of behavioural psychological research – a practice known as nudging. Very roughly, nudging means adjusting the way choices […]

Read More…

Not Just About Consent: The Ethical Dimensions of Research Methodology Knowledge in IRBs

Guest Post: Sarah Wieten The recent article, “Some Social Scientists Are Tired of Asking for Permission” in the New York Times inspired a great deal of debate about the role of institutional research ethics board (IRB) oversight in social science, which some argue is in most cases unlikely to involve significant harm to participants. While […]

Read More…

“NOW’s interest in pharmaceutical gender equity seems to have disappeared with its funding.”

There’s a remarkable piece on the Hastings Center’s blog by Alycia Hogenmiller about a drug called Addyi.  Addyi is a drug that doesn’t work to treat a condition that doesn’t exist, pushed by campaigners who are actually industry shills. Sprout Pharmaceuticals, run by Cindy and Robert Whitehead, was determined to obtain regulatory approval for flibanserin […]

Read More…